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A B S T R A C T
Background: Alcohol intake may increase the risk of prostate cancer (PCa). Many previous studies
harbored important methodological limitations.
Methods: We conducted a population-based case-control study of PCa comprising 1933 cases and
1994 controls in Montreal, Canada. Lifetime alcohol consumption was elicited, by type of beverage,
during in-person interviews. Odds ratios (OR) and 95% conﬁdence intervals (CI) assessed the association
between alcohol intake and PCa risk, adjusting for potential confounders and considering the subjects’
PCa screening history.
Results: We observed a weak, non-signiﬁcant positive association between high consumption of total
alcohol over the lifetime and risk of high-grade PCa (OR = 1.18, 95% CI 0.81–1.73). Risk estimates were
more pronounced among current drinkers (OR = 1.40, 95%CI 1.00–1.97), particularly after adjusting for the
timing of last PCa screening (OR = 1.52, 95%CI 1.07–2.16). These associations were largely driven by beer
consumption. The OR for high-grade PCa associated with high beer intake was 1.37 (95%CI 1.00–1.89); it
was 1.49 (95%CI 0.99–2.23) among current drinkers and 1.68 (95% CI 1.10–2.57) after adjusting for
screening recency. High cumulative consumption of spirits was associated with a lower risk of low-grade
PCa (OR = 0.75, 95%CI 0.60–0.94) but the risk estimate no longer achieved statistical signiﬁcance when
restricting to current users. No association was found for wine consumption.
Conclusion: Findings add to the accumulating evidence that high alcohol consumption increases the risk
of high-grade PCa. This association largely reﬂected beer intake in our population, and was strengthened
when taking into account PCa screening history.
ã 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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High alcohol intake is a risk factor for many cancers, including
those of the oral cavity, pharynx, larynx, esophagus, colorectum,
liver and female breast [1]. In 2012, the International Agency for
Research on Cancer concluded that there was little evidence inAbbreviations: PCa, prostate cancer; PSA, prostate screening antigen; DRE,
digital rectal exam; OR, odds ratio; CI, conﬁdence interval.
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beverages and risk of prostate cancer (PCa) [1]. However,
subsequent studies have suggested that alcohol intake might in
fact increase risks for this cancer [2–8]. In a meta-analysis
conducted recently, there was indication of a positive association
between alcohol consumption and risk of overall PCa [9].
Earlier studies may have been more likely to harbor methodo-
logical limitations, resulting in a shift in ﬁndings over time. These
include insufﬁcient statistical power, crude alcohol exposure
metrics, timing of assessment, non-differentiation of types of
beverages, low exposure levels in some study populations, use of
various disease endpoints, lack of consideration of cancer
aggressiveness, confounding or biases [1,10]. Recent reports also
stress the importance of considering PCa screening when studying
associations with alcohol use [11–13]. Moreover, previousnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(undiagnosed) cancers in non-cases.
The objective of the present study was to provide additional
evidence on the alcohol intake  PCa relationship while
minimizing previous methodological issues.
2. Materials and methods
2.1. Study population
We used data from the Prostate Cancer & Environment Study
(PROtEuS) [14], a large population-based case-control study in
Montreal assessing the role of potential risk factors in PCa
development.
Eligible subjects were men, younger than 76 years at diagnosis
or selection, residents of Greater Montreal, registered on Quebec’s
permanent electoral list (continually updated) and Canadian
citizen. Cases were all patients newly diagnosed with primary
PCa, actively ascertained through pathology departments across
the main French hospitals (7 out of 9 hospitals) in the Montreal
area between 2005 and 2009. Based on registry information, this
covered at least 80% of all PCa cases diagnosed in the area during
the study period. Control subjects were selected concurrently from
the population-based provincial electoral list of French-speaking
men, and frequency-matched to cases by 5-year age groups.
The participation rate among eligible subjects was 79% for cases
and 56% for controls. The study was approved by the Ethics
Committees of all participating institutions. All participants
provided written informed consent.
2.2. Data collection
Eligible subjects were sent an introductory package and were
reached by telephone by interviewers to set up an appointment. In-
person interviews collected socio-demographic and lifestyle
characteristics, family history of cancer, medical and PCa screening
histories, and self-reported weight and height. Subjects reported
their overall physical activity level at work (Very/Moderately/Not
very active), at home (Very/Moderately/Not very active) and their
engagement in any leisure physical activity during adulthood [15],
along with their frequency of use of 44 fruit and vegetables.
For subjects who reported ever consuming alcohol once a
month for one year or more, lifetime alcohol consumption was
recorded for beer, wine and spirits. Drinks were reported in
commonly used servings, i.e., 375 ml for beer, 125 ml for wine and
45 ml for spirits. For each beverage type, each time the pattern of
intake changed, participants were asked to report their drinking
habits, including the time period (age started and age ended) and
the frequency of drinking (number of drinks per month, week or
day). This allowed taking into account changes in intake levels over
the lifespan.
The degree of aggressiveness of PCa, deﬁned by the Gleason
score, was extracted from prostate biopsy pathology reports.
2.3. Exposure variables
Lifetime cumulative exposure variables were created for each
type of beverages. These were deﬁned as the product of the average
number of drinks consumed per day and the duration of drinking in
years for beer, wine, and spirits, and expressed as drink-years.
A composite exposure variable was also constructed to express
the cumulative exposure to total alcohol by taking into account the
ethanol content by volume of each type of beverages. Using the
quantities of 14.8 g of ethanol per drink of beer, 11.8 g per drink of
wine, and 14.2 g per drink of spirits [1,16], we calculated the
cumulative intake in total grams of ethanol. The latter was dividedby 14, which corresponds to the average amount of ethanol per
drink weighted by the proportion of each type of drink in our study
population, to estimate the total amount of alcohol used, in drink-
years, standardized for ethanol content.
2.4. Statistical analyses
Odds ratios (OR) and 95% conﬁdence intervals (CI) were used to
assess the association between alcohol consumption and PCa risk.
Risks of low-grade and high-grade (Gleason scores >7 or [4 + 3])
PCa were estimated using unconditional polytomous logistic
regression. Two models were developed. Model 1 was adjusted
for the age at diagnosis or interview (continuous), ancestry (Black/
Asian/European/Other), ﬁrst-degree family history of PCa (Yes/No),
education (Elementary/High School/College/University), smoking
(cigarette pack-years, continuous), overall physical activity (Very/
Moderately/Not very active), maximum body mass index (BMI,
continuous), frequency of use of fruit and vegetables (categorical),
and self-reported history of diabetes (Yes/No). Analyses focusing
on speciﬁc beverages were adjusted for other types of beverages.
Model 2 included all variables in Model 1 as well as the timing of
the last PCa screening by prostatic speciﬁc antigen (PSA) and/or
digital rectal exam (DRE) (Within the last 2 years, 2–5 years earlier,
More than 5 years earlier, Never screened, Don’t know).
Alcohol exposure was analyzed using quartiles of total alcohol,
beer and wine drink-years, and tertiles of spirit drink-years
(because of fewer drinkers) based on the distribution among
controls. Non-drinkers (subjects who reported having consumed
alcohol less than once a month over a year, or less) or non-drinkers
of the speciﬁc beverage under study constituted the reference
category in analyses for total alcohol and for speciﬁc beverages,
respectively.
Since men who stopped drinking or never drinkers may differ in
some qualitative way from current alcohol consumers, analyses
were also conducted among current drinkers, deﬁned as subjects
reporting drinking in the two years before diagnosis or interview.
In this analysis, subjects in the lowest quartile/tertile category
were considered as the reference.
Sensitivity analyses were also performed excluding proxy
respondents (<4% of subjects), restricting the sample to subjects
of European ancestry (86% of subjects), and restricting controls to
men who had been screened (PSA and/or DRE) in the 2 years
preceding the interview to reduce the likelihood of undiagnosed
PCa among controls.
3. Results
3.1. Study population
The characteristics of study participants are presented in Table 1.
Average age was about 64 years. The case series included a greater
proportion of subjects of African ancestry but a lower proportion of
Asian subjects than controls. Cases reported more often a ﬁrst-
degree family history of PCa than controls. A lower proportion of
cases than controls had been diagnosed with diabetes. Cases had a
slightly lower maximum BMI. About 99% of cases and 76% of controls
had been exposed to PCa early detection efforts in the form of PSA
and/or DRE testing within the 2 years preceding the interview. There
were little differences in terms of education, smoking history,
physical activity, and frequency of use of fruit and vegetables
according to case/control status.
3.2. Alcohol consumption patterns
Cases and controls presented similar percentages of never,
current and former users of total alcohol (Table 1). They also
Table 1
Characteristics of the study population, PROtEuS, Montreal, Canada.
Characteristics Cases (n = 1933) Controls (n = 1994) p-valuea
Age, mean  SD 64  7 65  7 <0.0001
Ancestry, n (%) <0.0001
Black 129 (7) 90 (5)
Asian 24 (1) 72 (4)
European 1693 (88) 1686 (85)
Other 75 (4) 132 (7)
Don’t know 12 (1) 14 (1)
First-degree family history of prostate cancer, n (%) <0.0001
No 1417 (73) 1738 (87)
Yes 450 (23) 199 (10)
Don’t know 66 (3) 57 (3)
Education, n (%) 0.15
Elementary 449 (23) 429 (22)
High School 576 (30) 578 (29)
College 313 (16) 375 (19)
University 590 (31) 610 (31)
Other 5 (0) 2 (0)
Smoking (pack-years), mean  SD 23  28 24  28 0.13
Physical activity, n (%) 0.09
Not very active 475 (25) 547 (27)
Moderately active 472 (24) 491 (25)
Very active 980 (51) 953 (48)
Don’t know 6 (0) 3 (0)
Maximum BMIb, mean  SD 28  4 29  5 <0.01
Daily frequency of use of fruit and vegetables, n (%) 0.22
6 476 (25) 498 (25)
[6–9] 506 (26) 497 (25)
[9–12] 430 (22) 497 (25)
>12 510 (26) 498 (25)
Don’t know 11 (1) 4 (0)
History of diabetes, n (%) <0.001
No 1640 (85) 1596 (80)
Yes 290 (15) 395 (20)
Don’t know 3 (0) 3 (0)
Timing of the last prostate cancer screening by PSA or DREc <0.0001
Within last 2 years 1913 (99) 1511 (76)
2–5 years earlier 1 (0) 154 (8)
More than 5 years earlier 0 (0) 81 (4)
Never screened 3 (0) 191 (10)
Don’t know 16 (1) 57 (3)
Alcohol users, n (%) 0.11
Never 215 (11) 231 (12)
Former 200 (10) 247 (12)
Current 1511 (78) 1513 (76)
Don’t know 7 (1) 3 (0)
Alcohol consumption in drink-years, mean  SD (% of ever users)
Beer 59  104 (74) 56  102 (74) 0.49
Wine 29  46 (72) 29  46 (72) 0.71
Spirits 27  70 (42) 30  98 (47) 0.36
Total alcohold 85  130 (88) 85  148 (88) 0.94
a p-values for Chi-Square test for differences of proportions or T-test for differences of means.
b BMI: body mass index.
c PSA: prostate speciﬁc antigen; DRE: digital rectal exam.
d Based on 14 g of ethanol per drink.
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slightly lower proportion of cases than controls reported having
drunk spirits. Beer was the most frequently consumed beverage in
this study population, with an overall cumulative frequency of use
about twice of that of wine or spirits. Among drinkers, mean total
alcohol consumption was the same between cases and controls.
Cases declared, on average, slightly higher beer consumption levelsthan controls, and lower spirits consumption levels, but differ-
ences were not statistically signiﬁcant.
3.3. Association between alcohol intake and PCa risk
Table 2 presents results for the association between lifetime
consumption of total alcohol, beer, wine and spirits, and the risk of
Table 2
Odds ratio (OR) and 95% conﬁdence interval (CI) for the association between lifetime alcohol consumption and prostate cancer risk, by disease aggressiveness, PROtEuS,
Montreal, Canada.
Model 1a Model 2b
Lifetime alcohol intake controls low-grade PCa high-grade PCa low-grade PCa high-grade PCa
n n OR (95%CI) n OR (95%CI) OR (95%CI) OR (95%CI)
Total alcohol
Never drank alcohol 231 159 ref 56 ref ref ref
16 drink-years 438 321 0.89 (0.68;1.17) 106 0.96 (0.66;1.40) 0.85 (0.64;1.14) 0.94 (0.63;1.38)
]16–45] drink-years 439 331 0.89 (0.68;1.17) 118 1.06 (0.72;1.55) 0.78 (0.58;1.04) 0.93 (0.63;1.38)
]45–101] drink-years 437 296 0.82 (0.63;1.09) 108 0.95 (0.64;1.39) 0.72 (0.53;0.97) 0.84 (0.56;1.26)
>101 drink-years 439 274 0.80 (0.60;1.06) 140 1.18 (0.81;1.73) 0.80 (0.59;1.08) 1.21 (0.82;1.80)
p for trendc p = 0.15 p = 0.20 p = 0.42 p = 0.08
Beer
Never drank beer 522 376 ref 120 ref ref ref
6 drink-years 366 262 0.83 (0.66;1.04) 98 1.18 (0.86;1.62) 0.79 (0.62;1.00) 1.13 (0.82;1.58)
]6–23] drink-years 364 259 0.83 (0.66;1.05) 96 1.20 (0.87;1.66) 0.78 (0.61;0.99) 1.14 (0.82;1.59)
]23–63] drink-years 369 248 0.83 (0.66;1.05) 93 1.12 (0.81;1.56) 0.80 (0.63;1.02) 1.09 (0.78;1.53)
>63 drink-years 367 242 0.83 (0.65;1.05) 124 1.37 (1.00;1.89) 0.85 (0.66;1.10) 1.46 (1.04;2.03)
p for trendc p = 0.39 p = 0.11 p = 0.80 p = 0.04
Wine
Never drank wine 561 362 ref 167 ref ref ref
4 drink-years 361 269 1.12 (0.90;1.41) 93 0.88 (0.65;1.20) 1.03 (0.81;1.31) 0.79 (0.58;1.09)
]4–13] drink-years 343 258 1.07 (0.84;1.35) 91 0.92 (0.67;1.26) 0.93 (0.72;1.19) 0.79 (0.56;1.09)
]13–35] drink-years 369 247 0.97 (0.76;1.24) 86 0.82 (0.59;1.15) 0.86 (0.66;1.12) 0.72 (0.52;1.02)
>35 drink-years 356 252 1.12 (0.88;1.43) 95 0.99 (0.72;1.37) 0.98 (0.76;1.26) 0.87 (0.62;1.21)
p for trendc p = 0.58 p = 0.73 p = 0.08 p = 0.94
Spirits
Never drank spirits 1,047 797 ref 305 ref ref ref
3 drink-years 312 212 0.86 (0.70;1.07) 68 0.78 (0.57;1.05) 0.86 (0.69;1.08) 0.78 (0.57;1.06)
]3–15] drink-years 309 215 0.94 (0.76;1.17) 72 0.81 (0.60;1.10) 0.92 (0.74;1.15) 0.79 (0.58;1.08)
>15 drink-years 321 164 0.75 (0.60;0.94) 85 0.92 (0.69;1.23) 0.78 (0.61;0.99) 0.96 (0.71;1.30)
p for trendc p = 0.02 p = 0.87 p = 0.07 p = 0.89
a Model 1 adjusted for age, ancestry, family history of prostate cancer, education, smoking, physical activity, body mass index, fruit and vegetables consumption, history of
diabetes and other types of beverages.
b Model 2 adjusted for variables in Model 1 as well as for timing since last prostate cancer screening.
c p for trend using an ordinal variable corresponding to the median drink-years of the category.
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before (Model 1) and after (Model 2) adjusting for the timing of last
PCa screening. We observed a slight, non-signiﬁcant increase in
risk of high-grade PCa (OR = 1.18, 95% CI 0.81–1.73) among men in
the highest cumulative intake category (over 101 drink-years) of
total alcohol. However, men in the upper quartile of beer
consumption (over 63 drink-years) had an increased risk of
high-grade PCa (Model 1: OR = 1.37, 95% CI 1.00–1.89). This
relationship was more pronounced (Model 2: OR = 1.46, 95% CI
1.04–2.03, p for trend = 0.04) when adjusting for the timing of last
PCa screening. No association emerged for wine consumption.
Contrastingly, men in the upper tertile of spirits consumption had a
reduced risk of low-grade PCa risk; for those consuming more than
15 drink-years the OR was 0.75 (95% CI 0.60–0.94), based on Model
1. After adjusting for the timing of last PCa screening, this
association was slightly weakened (Model 2: OR = 0.78, 95% CI
0.61–0.99).
Excluding former and never drinkers from the analyses had
little inﬂuence on ﬁndings for low-grade PCa (Table 3). However,
this resulted in greater risks of high-grade cancers, which was true
for the highest levels of consumption for total alcohol, and for all
three speciﬁc beverages. For instance, results from Model 2 show
statistically signiﬁcant increases in risk of high-grade PCa for high
consumption levels of total alcohol (OR = 1.52, 95% CI 1.07–2.16)
and beer (OR = 1.68, 95%CI 1.10–2.57). Both relationships exhibited
statistically signiﬁcant dose-response trends.Analyses restricted to former drinkers (who quit drinking more
than 2 years before the index date) showed lower risks for the
upper category of total alcohol consumption for high-grade PCa
(OR = 0.75, 95%CI 0.34–1.63) but numbers were small (247 controls,
128 low-grade and 72 high-grade PCa).
Exclusion of proxy respondents did not alter ﬁndings, nor did
the restriction to European subjects, or to controls recently
screened (data not shown).
We compared PSA levels at diagnosis among cases across
quartiles of total alcohol intake. There was no evidence of an
association between alcohol intake levels and PSA levels, either
among low- or high-grade cases (data not shown).
4. Discussion
We observed an increased risk of high-grade PCa among current
alcohol users, largely driven by beer drinking. The lower numbers
of wine and spirits users might explain the lack of clear
associations for these beverages. Although trend analyses sug-
gested some dose-response relationships, signiﬁcant associations
emerged only for upper intake categories, raising the possibility of
a threshold effect. Under a hypothetical scenario, assuming that
men having consumed over 101 drink-years over their lifetime had
started drinking at age 20, this would translate into >2 drinks/day
for a 65 year old man, or >3 drinks/day for a 50 year old man. These
are above levels currently considered not to be harmful to general
Table 3
Odds ratio (OR) and 95% conﬁdence interval (CI) for the association between lifetime alcohol consumption among current drinkers and prostate cancer risk, by disease
aggressiveness, PROtEuS, Montreal, Canada.
Model 1a Model 2b
Lifetime alcohol intake controls low-grade PCa high-grade PCa low-grade PCa high-grade PCa
n n OR (95%CI) n OR (95%CI) OR (95%CI) OR (95%CI)
Total alcohol
16 drink-years 365 287 ref 87 ref ref ref
]16–45] drink-years 396 306 0.97 (0.77;1.21) 103 1.09 (0.79;1.51) 0.90 (0.71;1.14) 1.00 (0.71;1.39)
]45–101] drink-years 404 272 0.88 (0.70;1.11) 92 0.94 (0.67;1.31) 0.81 (0.64;1.04) 0.87 (0.62;1.24)
>101 drink-years 343 229 0.89 (0.69;1.14) 119 1.40 (1.00;1.97) 0.97 (0.74;1.27) 1.52 (1.07;2.16)
p for trendc p = 0.34 p = 0.04 p = 0.97 p = 0.01
Beer
6 drink-years 268 199 ref 64 ref ref ref
]6–23] drink-years 277 201 1.04 (0.79;1.37) 72 1.11 (0.75;1.64) 1.02 (0.76;1.36) 1.08 (0.72;1.61)
]23–63] drink-years 282 208 1.13 (0.86;1.49) 66 1.00 (0.67;1.49) 1.15 (0.86;1.54) 1.01 (0.67;1.53)
>63 drink-years 234 176 1.11 (0.82;1.51) 94 1.49 (0.99;2.23) 1.25 (0.90;1.74) 1.68 (1.10;2.57)
p for trendc p = 0.55 p = 0.04 p = 0.15 p = 0.01
Wine
4 drink-years 318 242 ref 81 ref ref ref
]4–13] drink-years 314 241 0.94 (0.73;1.21) 81 1.01 (0.71;1.44) 0.89 (0.69;1.16) 0.96 (0.67;1.39)
]13–35] drink-years 340 237 0.88 (0.68;1.13) 80 0.95 (0.66;1.36) 0.85 (0.65;1.11) 0.93 (0.64;1.34)
>35 drink-years 316 224 0.96 (0.75;1.25) 86 1.17 (0.82;1.67) 0.92 (0.71;1.21) 1.14 (0.79;1.64)
p for trendc p = 0.96 p = 0.32 p = 0.71 p = 0.07
Spirits
3 drink-years 208 146 ref 37 ref ref ref
]3–15] drink-years 207 127 0.96 (0.69;1.33) 36 0.92 (0.55;1.55) 0.96 (0.68;1.36) 0.92 (0.54;1.57)
>15 drink-years 181 87 0.86 (0.59;1.23) 43 1.40 (0.84;2.36) 0.92 (0.63;1.36) 1.49 (0.87;2.54)
p for trendc p = 0.41 p = 0.11 p = 0.85 p = 0.34
a Model 1 adjusted for age, ancestry, family history of prostate cancer, education, smoking, physical activity, body mass index, fruit and vegetables consumption, history of
diabetes and other types of beverages.
b Model 2 adjusted for variables in Model 1 as well as for timing since last prostate cancer screening.
c p for trend using an ordinal variable corresponding to the median drink-years of the category.
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uncommon in our study population (22% of controls).
4.1. Former evidence
In a recent meta-analysis [9], relative risks of overall PCa were
1.04 (95% CI 1.01–1.08), 1.06 (95% CI 1.01–1.11) and 1.09 (95% CI
0.98–1.21) for light, moderate and heavy alcohol drinkers,
respectively. Pooled relative risks were similar for case-control
and cohort studies, but more pronounced in North American
populations, especially among heavy drinkers. Analyses were not
performed according to cancer aggressiveness. Subsequently, a
large cohort study in the United-States found a non-signiﬁcant
increased risk of overall PCa with lifelong intake in average drinks
per day [17]. In the Asian Cohort Consortium, no association was
found with PCa mortality [11]. However, Murphy et al. [13]
highlighted that the most consistent relationships between alcohol
consumption and PCa were found at consumption levels higher
than those observed in the Asian Consortium, which is the case for
our study population. In a nested case-control study conducted in
the United Kingdom, a small increase in risk of high-grade and a
decreased risk of low-grade PCa was reported for higher levels of
usual weekly intake in the previous year [8]. In a prospective study,
Sawada et al. observed a dose-dependent association between the
frequency of use of alcohol at baseline and advanced PCa in
Japanese men [6]. In a Brazilian case-control study [4], higher
current alcohol consumption levels increased the risk of develop-
ing overall PCa. In a case-control study from Alberta, Canada,
McGregor et al. found that lifetime alcohol consumption increased
risk for both non-aggressive and aggressive cancers, but only beer
intake achieved statistical signiﬁcance [3]. In this latter study,
stages T1 were excluded and cases were classiﬁed as non-aggressive if they were stage II and Gleason score <8 whereas
in our study, 75% of low-grade PCa had T1 clinical stage. Differences
in aggressiveness deﬁnitions in the two Canadian studies may
possibly explain the different ﬁndings for less aggressive cancers.
4.2. Methodological considerations
4.2.1. Alcohol exposure assessment
Alcohol consumption was self-reported, necessarily entailing
some measurement error. If misclassiﬁcation was non-differential,
this attenuated true associations. Recall bias, whereas cases could
over-report their alcohol consumption, is a potential problem in
case-control studies. However, several observations suggest that
this is probably not the main underlying explanation to our
ﬁndings. First, cases and controls declared the same average
cumulative intake of total alcohol over their lifetime. Second,
under an over-reporting scenario by cases, one would have
expected that higher risks would have emerged for all beverage
types, which is not what we observed. Third, positive associations,
especially for beer, were observed for high-grade but not for low-
grade PCa. It is unclear why cases in the former group would have
tended to over-report their intake levels to a greater extent than
those in the latter. In a previous validation study, recall bias was
found to have only minor effects on reported intake of alcohol [18].
In addition, there is no widespread public knowledge that alcohol
intake increases the risk of PCa, which could have led to over-
reports by cases, or biased interviewers who could not be blinded
to the disease status of participants. Similar pooled estimates from
cohort and case-control studies further argue against recall bias
issues [9].
Our assessment covered exposure over the lifetime, considering
beverage sizes, intensity, frequency and duration of use. It
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consumption periods speciﬁc to each respondent. Many previous
studies did not collect information on types of beverages and
modelled grams of ethanol in average consumption patterns at a
given point in time, rather than over the lifetime. We used an
exposure metric that captures both the intensity and duration of
alcohol consumption. Such an approach is frequently used for
other lifestyle exposures in epidemiologic investigations, such as
cigarette smoking [19]. Cumulative exposure over the lifetime may
be a better predictor of disease than assessment at one time point,
especially if intake patterns changed over time. Moreover, our
variable representing total alcohol considered the ethanol content
of the different types of beverages, which is relevant when a drink
is the unit of measurement.
Like most others, our study did not collect information on binge
drinking. Due to its often episodic nature, binge drinking is
particularly difﬁcult to assess with validity [20].
4.2.2. Selection bias
Selection bias based on alcohol use is unlikely to have occurred,
other perhaps than for individuals with very severe consumption
issues. We assessed the possibility of selection bias in the study
based on factors that could be related to alcohol use. A comparison
of non-respondents to respondents in terms of several census-
based socio-economic variables (education, income, unemploy-
ment, % of recent immigrants) revealed minimal differences,
suggesting that selection bias in the study is not of concern.
Moreover, there was no mention to potential participants that the
study assessed alcohol intake patterns, which could also have led
to differential selection based on alcohol use.
4.2.3. Current drinkers
In our analyses focusing on current drinkers, the associations
for high-grade PCa were positive in the upper intake category for
total alcohol as well as for all individual beverages, although
statistical signiﬁcance was reached for total alcohol and beer only.
One can speculate that high levels of alcohol close to diagnosis
might have a promoting effect with respect to high-grade cancer.
Alternatively, it may be that former drinkers had speciﬁc
characteristics that are related to both alcohol use and PCa risk.
4.2.4. Prostate cancer screening
It is now well recognized that lack of proper consideration of
screening practices in Europe and North America may have
seriously hampered the progress in the identiﬁcation of risk factors
for PCa in those populations [12,21]. The current study was
conducted in the Province of Quebec, where health care is free and
universal. Although PCa screening is not practiced or recom-
mended there, at the time subjects were ascertained the practice of
PSA measurement (which became available in the early 1990s),
DRE or both was relatively frequent, often incorporated as part of
yearly routine exams. Unlike most previous studies, we collected a
detailed screening history, enabling us to assess potential inﬂuence
of screening on the associations studied.
Substantial alcohol drinking may relate to lifestyle and health-
related behaviors, including screening, and thus act as a
confounder of alcohol-PCa associations. Taking into account
screening practices had an appreciable inﬂuence on relationships,
strengthening the positive association for total alcohol and beer
consumption, whereas it drew the negative association for spirits
consumption towards the null.
In cohort and case-control studies, the true PCa status of men
being followed-up or of controls is typically unknown, potentially
compromising the ability to observe associations. Our access to PCa
screening information allowed us to conduct a sub-analysis
excluding controls not screened within the previous two years(24% of controls) and thus more likely to have latent, undiagnosed
PCa. This had a marginal inﬂuence on our ﬁndings, probably
because of the generally high screening rates in our population at
the time of study.
Theoretically, heavy beer drinkers could have been more likely
to get screened for PCa if experiencing health-related symptoms.
However, there was no evidence of this in our study as the
percentages of subjects screened within the previous two years
were similar across alcohol intake categories.
4.2.5. Confounding
Our models were adjusted for a wide range of socio-
demographic and lifestyle characteristics, and the high beer
intake—high-grade PCa association persisted. Nevertheless, re-
sidual confounding or confounding by an unmeasured factor,
perhaps one speciﬁcally related to beer drinking, remains a
possibility.
4.3. Mechanisms
The postulated biological underlying mechanisms between
alcohol intake and cancer are numerous, but not fully understood,
particularly with respect to PCa. Acetaldehyde, the ﬁrst metabolite
of ethanol, is a carcinogen that can promote cancer development
through several mechanisms, including interference with DNA
replication, induction of DNA damage, and formation of DNA
adducts. Some of these mechanisms involve polymorphisms in
genes that encode the alcohol dehydrogenase and aldehyde
dehydrogenase enzymes for the metabolism of ethanol and
acetaldehyde affecting the ethanol/acetaldehyde oxidising capaci-
ty [22], reactive oxygen species generated predominantly by
cytochrome P450 2E1 (CYP2E1), particularly after chronic heavy
alcohol consumption and leading to oxidative stress [1,22,23].
Studies of genetic variants using Mendelian randomization [24]
may thus help towards a better understanding of the alcohol-PCa
association. Other hypotheses concern folate deﬁciency due to
ethanol associated with high alcoholic beverage consumption
[25,26] or immunosuppression that may facilitate tumor spread
[27]. If alcohol plays a role in PCa development, it could also be by
shifting the balance between androgens and estrogens. Alcohol
may alter hormonal proﬁles through diminishing testicular
function and lowering circulating testosterone [25]. These poten-
tial mechanisms would apply regardless of the type of beverages
consumed. Positive associations were largely attributable to beer
intake in our study, as observed previously [3,28]. To our
knowledge, no mechanism has been proposed to date to explain
a speciﬁc role of beer intake in PCa.
5. Conclusions
Results from this study provide evidence that high alcohol
consumption levels over the lifetime increase the risk of high-
grade PCa. This relationship was largely driven by beer consump-
tion and was stronger among current alcohol users. No increase in
risk was observed for low grade PCa. Our ﬁndings also point out to
the importance of considering PCa screening practices, which have
been largely ignored in the past, when studying this association.
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